Skip to main content
Erschienen in: Cancer Causes & Control 3/2013

01.03.2013 | Original paper

Clustering of place of birth for women with breast cancer: differences by tumor characteristics

verfasst von: Daikwon Han, Jing Nie, Matthew R. Bonner, Christine Ambrosone, Catalin Marian, Peter Shields, Maurizio Trevisan, Stephen B. Edge, Jo L. Freudenheim

Erschienen in: Cancer Causes & Control | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

There is increasing evidence that exposures in early life affect breast cancer risk, and that breast cancer etiology differs by tumor subtype. If environmental exposures in early life contribute to risk, it is expected that there would be clustering of women with breast cancer by their place of birth, and that clustering might differ by subtype. We examined spatial associations between place of birth and breast cancer by subtype, using hormone receptor status and molecular profiles of breast tumors.

Methods

Data were drawn from the Western New York Exposures and Breast Cancer study, a population-based case–control study of incident, pathologically confirmed breast cancer (1996–2001) in Erie and Niagara Counties. Included were women born in the study area (579 cases and 931 controls). Clustering of breast cancer subgroups relative to controls was examined by the k-function method in groups stratified by estrogen receptor (ER), progesterone receptor (PR), and HER2 status, and by DNA methylation status and p53 mutation status, and the k-function difference was used to compare relative spatial aggregation and spatial range of the difference between case subgroups and controls.

Results

We found a tendency to cluster among ER positive, PR positive, and HER2 negative cases (i.e., luminal A subtype), especially among premenopausal women, but not among the other groups defined by hormonal receptor status, or by either methylation or p53 mutation status.

Conclusions

While our findings cannot rule out clustering of cases by birth place because of shared behaviors related to residence location, they also suggest that early life environmental exposures may affect subsequent breast cancer risk, and that premenopausal breast tumors of the luminal A subtype may be more affected by these early life exposures than other subtypes.
Literatur
1.
Zurück zum Zitat Lacey JV Jr, Devesa SS, Brinton LA (2002) Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 39:82–88PubMedCrossRef Lacey JV Jr, Devesa SS, Brinton LA (2002) Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen 39:82–88PubMedCrossRef
2.
Zurück zum Zitat Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13:1558–1568PubMed Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13:1558–1568PubMed
3.
Zurück zum Zitat Li CI, Anderson BO, Daling JR, Moe RE (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289:1421–1424PubMedCrossRef Li CI, Anderson BO, Daling JR, Moe RE (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289:1421–1424PubMedCrossRef
4.
Zurück zum Zitat Perou CM, Sorlie T, Eisen MB, Van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A et al (2000) Molecular portraits of human breast tumors. Nature 406:747–752PubMedCrossRef Perou CM, Sorlie T, Eisen MB, Van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A et al (2000) Molecular portraits of human breast tumors. Nature 406:747–752PubMedCrossRef
5.
Zurück zum Zitat Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502PubMedCrossRef Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502PubMedCrossRef
6.
Zurück zum Zitat Gregorio DI, Kulldorff M, Barry L, Samociuk H (2002) Geographic differences in invasive and in situ breast cancer incidence according to precise geographic coordinates, Connecticut, 1991-95. Int J Cancer 100:194–198PubMedCrossRef Gregorio DI, Kulldorff M, Barry L, Samociuk H (2002) Geographic differences in invasive and in situ breast cancer incidence according to precise geographic coordinates, Connecticut, 1991-95. Int J Cancer 100:194–198PubMedCrossRef
7.
Zurück zum Zitat Sheehan TJ, DeChello LM (2005) A space-time analysis of the proportion of late stage breast cancer in Massachusetts, 1988 to 1997. Int J Health Geogr 4:15PubMedCrossRef Sheehan TJ, DeChello LM (2005) A space-time analysis of the proportion of late stage breast cancer in Massachusetts, 1988 to 1997. Int J Health Geogr 4:15PubMedCrossRef
8.
Zurück zum Zitat Benz CC, Clarke CA, Moore DH 2nd (2003) Geographic excess of estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 12:1523–1527PubMed Benz CC, Clarke CA, Moore DH 2nd (2003) Geographic excess of estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 12:1523–1527PubMed
9.
Zurück zum Zitat Han D, Rogerson PA, Nie J, Bonner MR, Vena JE, Muti P, Trevisan M, Edge SB, Freudenheim JL (2004) Geographic clustering of residence in early life and subsequent risk of breast cancer (United States). Cancer Causes Control 15:921–929PubMedCrossRef Han D, Rogerson PA, Nie J, Bonner MR, Vena JE, Muti P, Trevisan M, Edge SB, Freudenheim JL (2004) Geographic clustering of residence in early life and subsequent risk of breast cancer (United States). Cancer Causes Control 15:921–929PubMedCrossRef
10.
Zurück zum Zitat Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathol 11:155–168 Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathol 11:155–168
11.
Zurück zum Zitat Tennis M, Krishnan S, Bonner M, Ambrosone CB, Vena JE, Moysich K, Swede H, McCann S, Hall P, Shields PG, Freudenheim JL (2006) p53 Mutation analysis in breast tumors by a DNA microarray method. Cancer Epidemiol Biomarkers Prev 15:80–85PubMedCrossRef Tennis M, Krishnan S, Bonner M, Ambrosone CB, Vena JE, Moysich K, Swede H, McCann S, Hall P, Shields PG, Freudenheim JL (2006) p53 Mutation analysis in breast tumors by a DNA microarray method. Cancer Epidemiol Biomarkers Prev 15:80–85PubMedCrossRef
13.
Zurück zum Zitat Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103:250–263PubMedCrossRef Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103:250–263PubMedCrossRef
14.
Zurück zum Zitat Xue F, Michels KB (2007) Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol 8:1088–1100PubMedCrossRef Xue F, Michels KB (2007) Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol 8:1088–1100PubMedCrossRef
15.
Zurück zum Zitat Silva IdS, Stavola BD, McCormack V, Collaborative Group on Pre-Natal Risk Factors and Subsequent Risk of Breast Cancer (2008) Birth size and breast cancer risk: re-analysis of individual participant data from 32 Studies. PLoS Med 5:e193CrossRef Silva IdS, Stavola BD, McCormack V, Collaborative Group on Pre-Natal Risk Factors and Subsequent Risk of Breast Cancer (2008) Birth size and breast cancer risk: re-analysis of individual participant data from 32 Studies. PLoS Med 5:e193CrossRef
16.
Zurück zum Zitat Park SK, Kang D, McGlynn KA, Garcia-Closas M, Kim Y, Yoo KY, Brinton LA (2008) Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res 10(1):R8PubMedCrossRef Park SK, Kang D, McGlynn KA, Garcia-Closas M, Kim Y, Yoo KY, Brinton LA (2008) Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res 10(1):R8PubMedCrossRef
17.
Zurück zum Zitat Naccarato AG, Viacava P, Vignati S, Fanelli G, Bonadio AG, Montruccoli G, Bevilacqua G (2000) Bio-morphological events in the development of the human female mammary gland from fetal age to puberty. Virchows Arch 436:431–438PubMedCrossRef Naccarato AG, Viacava P, Vignati S, Fanelli G, Bonadio AG, Montruccoli G, Bevilacqua G (2000) Bio-morphological events in the development of the human female mammary gland from fetal age to puberty. Virchows Arch 436:431–438PubMedCrossRef
18.
Zurück zum Zitat Michels KB, Xue F, Terry KL, Willett WC (2006) Longitudinal study of birthweight and the incidence of breast cancer in adulthood. Carcinogenesis 27:2464–2468PubMedCrossRef Michels KB, Xue F, Terry KL, Willett WC (2006) Longitudinal study of birthweight and the incidence of breast cancer in adulthood. Carcinogenesis 27:2464–2468PubMedCrossRef
19.
Zurück zum Zitat Hurley S, Goldberg D, Von Behren J, Quach T, Layefsky M, Reynolds P (2011) Birth size and breast cancer risk among young California-born women. Cancer Causes Control 22:1461–1470PubMedCrossRef Hurley S, Goldberg D, Von Behren J, Quach T, Layefsky M, Reynolds P (2011) Birth size and breast cancer risk among young California-born women. Cancer Causes Control 22:1461–1470PubMedCrossRef
20.
Zurück zum Zitat Ahlgren M, Sørensen T, Wohlfahrt J, Haflidadóttir A, Holst C, Melbye M (2003) Birth weight and risk of breast cancer in a cohort of 106,504 women. Int J Cancer 107:997–1000PubMedCrossRef Ahlgren M, Sørensen T, Wohlfahrt J, Haflidadóttir A, Holst C, Melbye M (2003) Birth weight and risk of breast cancer in a cohort of 106,504 women. Int J Cancer 107:997–1000PubMedCrossRef
21.
Zurück zum Zitat Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151:703–714PubMedCrossRef Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG (2000) Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151:703–714PubMedCrossRef
22.
Zurück zum Zitat Troisi R, Hatch EE, Titus-Ernstoff L, Hyer M, Palmer JR, Robboy SJ, Strohsnitter WC, Kaufman R, Herbst AL, Hoover RN (2007) Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer 121:356–360PubMedCrossRef Troisi R, Hatch EE, Titus-Ernstoff L, Hyer M, Palmer JR, Robboy SJ, Strohsnitter WC, Kaufman R, Herbst AL, Hoover RN (2007) Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer 121:356–360PubMedCrossRef
23.
Zurück zum Zitat Palmer JR, Hatch EE, Rosenberg CL, Hartge P, Kaufman RH, Titus-Ernstoff L, Noller KL, Herbst AL, Rao RS, Troisi R, Colton T, Hoover RN (2002) Risk of breast cancer in women exposed to diethylstilbestrol in utero: preliminary results (United States). Cancer Causes Control 13:753–758PubMedCrossRef Palmer JR, Hatch EE, Rosenberg CL, Hartge P, Kaufman RH, Titus-Ernstoff L, Noller KL, Herbst AL, Rao RS, Troisi R, Colton T, Hoover RN (2002) Risk of breast cancer in women exposed to diethylstilbestrol in utero: preliminary results (United States). Cancer Causes Control 13:753–758PubMedCrossRef
24.
Zurück zum Zitat Hoover RN, Hyer M, Pfeiffer RM, Adam E, Bond B, Cheville AL, Colton T, Hartge P, Hatch EE, Herbst AL, Karlan BY, Kaufman R et al (2011) Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 365:1304–1314PubMedCrossRef Hoover RN, Hyer M, Pfeiffer RM, Adam E, Bond B, Cheville AL, Colton T, Hartge P, Hatch EE, Herbst AL, Karlan BY, Kaufman R et al (2011) Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 365:1304–1314PubMedCrossRef
25.
Zurück zum Zitat Palmer JR, Wise LA, Hatch EE, Troisi R, Titus-Ernstoff L, Strohsnitter W, Kaufman R, Herbst AL, Noller KL, Hyer M, Hoover RN (2006) Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15:1509–1514PubMedCrossRef Palmer JR, Wise LA, Hatch EE, Troisi R, Titus-Ernstoff L, Strohsnitter W, Kaufman R, Herbst AL, Noller KL, Hyer M, Hoover RN (2006) Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15:1509–1514PubMedCrossRef
26.
Zurück zum Zitat Troisi R, Potischman N, Hoover RN (2007) Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: a review and commentary. Cancer Epidemiol Biomarkers Prev 16:1700–1712PubMedCrossRef Troisi R, Potischman N, Hoover RN (2007) Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: a review and commentary. Cancer Epidemiol Biomarkers Prev 16:1700–1712PubMedCrossRef
27.
Zurück zum Zitat Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819–1826PubMedCrossRef Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819–1826PubMedCrossRef
28.
Zurück zum Zitat Kolonel L, Wilkens L (2006) Migrant Studies. In: Schottenfeld D, Fraumeni J (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York, pp 189–201CrossRef Kolonel L, Wilkens L (2006) Migrant Studies. In: Schottenfeld D, Fraumeni J (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York, pp 189–201CrossRef
29.
Zurück zum Zitat Falk RT, Fears TR, Hoover RN, Pike MC, Wu AH, Nomura AM, Kolonel LN, West DW, Ziegler RG (2002) Does place of birth influence endogenous hormone levels in Asian-American women? Br J Cancer 87:54–60PubMedCrossRef Falk RT, Fears TR, Hoover RN, Pike MC, Wu AH, Nomura AM, Kolonel LN, West DW, Ziegler RG (2002) Does place of birth influence endogenous hormone levels in Asian-American women? Br J Cancer 87:54–60PubMedCrossRef
30.
Zurück zum Zitat Bonner MR, Han D, Nie J, Rogerson PA, Vena JE, Muti P, Trevisan M, Edge SB, Freudenheim JL (2005) Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev 14:53–60PubMed Bonner MR, Han D, Nie J, Rogerson PA, Vena JE, Muti P, Trevisan M, Edge SB, Freudenheim JL (2005) Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev 14:53–60PubMed
31.
Zurück zum Zitat Crouse DL, Goldberg MS, Ross NA, Chen H, Labrèche F (2010) Postmenopausal breast cancer is associated with exposure to traffic-related air pollution in Montreal, Canada: a case-control study. Environ Health Perspect 118:1578–1583PubMedCrossRef Crouse DL, Goldberg MS, Ross NA, Chen H, Labrèche F (2010) Postmenopausal breast cancer is associated with exposure to traffic-related air pollution in Montreal, Canada: a case-control study. Environ Health Perspect 118:1578–1583PubMedCrossRef
32.
Zurück zum Zitat Nie J, Beyea J, Bonner MR, Han D, Vena J, Rogerson P, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL (2007) Exposure to traffic emissions throughout life and risk of breast cancer: the Western New York Exposures and Breast Cancer (WEB) study. Cancer Causes Control 18:947–955PubMedCrossRef Nie J, Beyea J, Bonner MR, Han D, Vena J, Rogerson P, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL (2007) Exposure to traffic emissions throughout life and risk of breast cancer: the Western New York Exposures and Breast Cancer (WEB) study. Cancer Causes Control 18:947–955PubMedCrossRef
33.
Zurück zum Zitat Petralia SA, Vena JE, Freudenheim JL, Dosemeci M, Michalek A, Goldberg MS, Brasure J, Graham S (1999) Risk of premenopausal breast cancer in association with occupational exposure to polycyclic aromatic hydrocarbons and benzene. Scand J Work Environ Health 25:215–221PubMedCrossRef Petralia SA, Vena JE, Freudenheim JL, Dosemeci M, Michalek A, Goldberg MS, Brasure J, Graham S (1999) Risk of premenopausal breast cancer in association with occupational exposure to polycyclic aromatic hydrocarbons and benzene. Scand J Work Environ Health 25:215–221PubMedCrossRef
34.
Zurück zum Zitat Brody JG, Moysich KB, Humblet O, Attfield KR, Beehler GP, Rudel RA (2007) Environmental pollutants and breast cancer. Cancer 109:2667–2711PubMedCrossRef Brody JG, Moysich KB, Humblet O, Attfield KR, Beehler GP, Rudel RA (2007) Environmental pollutants and breast cancer. Cancer 109:2667–2711PubMedCrossRef
35.
Zurück zum Zitat Safe SH (1997) Is there an association between exposure to environmental estrogens and breast cancer? Environ Health Perspect 105(Suppl 3):675–678PubMedCrossRef Safe SH (1997) Is there an association between exposure to environmental estrogens and breast cancer? Environ Health Perspect 105(Suppl 3):675–678PubMedCrossRef
Metadaten
Titel
Clustering of place of birth for women with breast cancer: differences by tumor characteristics
verfasst von
Daikwon Han
Jing Nie
Matthew R. Bonner
Christine Ambrosone
Catalin Marian
Peter Shields
Maurizio Trevisan
Stephen B. Edge
Jo L. Freudenheim
Publikationsdatum
01.03.2013
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 3/2013
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-9997-7

Weitere Artikel der Ausgabe 3/2013

Cancer Causes & Control 3/2013 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.